E Seeberger
The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study
Bolliger D, Seeberger M, Lurati Buse G, Christen P, Seeberger E, Ruppen W, Filipovic M. The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study. Anaesthesia 2011; 67:149-57.
09.11.2011The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study
09.11.2011Anaesthesia 2011; 67:149-57
Bolliger D, Seeberger M D, Lurati Buse G, Christen P, Seeberger E, Ruppen W, Filipovic Miodrag
Remifentanil does not impair left ventricular systolic and diastolic function in young healthy patients
Bolliger D, Seeberger M, Kasper J, Skarvan K, Seeberger E, Lurati Buse G, Buser P, Filipovic M. Remifentanil does not impair left ventricular systolic and diastolic function in young healthy patients. Br J Anaesth 2011; 106:573-9.
27.01.2011Remifentanil does not impair left ventricular systolic and diastolic function in young healthy patients
27.01.2011Br J Anaesth 2011; 106:573-9
Bolliger D, Seeberger M D, Kasper J, Skarvan K, Seeberger E, Lurati Buse G, Buser P, Filipovic Miodrag